Presented with both Excellence in Innovation and Technology
The Excellence in Innovation Award was presented by Kevin Traynor, Belfast Telegraph Digital Director to Dr William Watters, Isotope Chemistry Manager at the Sciences Business Unit
Almac is delighted to announce the exceptional achievement of picking up two category awards at the prestigious Belfast Telegraph Business Award gala ceremony in association with British Airways. The awards are in their 12th year and are the premier symbol in Northern Ireland of commercial, industrial and social enterprise achievements.
The winning Excellence in Innovation entry focused on the development of the company's Antibody Drug Conjugation (ADC) offering provided by the Science’s biocatalysis group headed up by Professor Tom Moody. Almac has developed the innovative ADC science from the laboratory bench into successful, novel, commercial offerings that are now part of its existing business portfolio.
The trophy was presented by Kevin Traynor, Belfast Telegraph’s Digital Director, to Dr William Watters, Isotope Chemistry Manager at Almac’s Sciences Business Unit. The other two finalists in this category were Core Systems and Randox Laboratories.
The Excellence in Technology award recognised the advances made by the Diagnostics team in relation to the recently announced DNA Damage Repair Deficiency (DDRD) research. This new technology offers significant advances in the treatment of cancer and has recently been the subject of a collaboration with US-based Genomic Health to bring its benefits to patients worldwide.
Michael Sloan, VP Business Development for the Diagnostics Business Unit received the Excellence in Technology Award from Karen Blair, MD, Clever Fulton Rankin
The trophy was collected by Michael Sloan, VP Business Development for the Diagnostics Business Unit from Karen Blair, MD, Clever Fulton Rankin who sponsored the award. Other finalists in this category were PathXL and Taggled.
'We are delighted to receive these prestigious awards and this is a tremendous tribute to the pioneering work carried out on a daily basis by our dedicated and talented teams here at Almac,' said Alan Armstrong, CEO, Almac Group. 'It is especially pleasing to achieve recognition for our work within the context of such strong local competition and is testimony to the true innovation and technology that we pride ourselves on within the pharmaceutical and biotech industry.'